It can be caused by various factors, such as chronic inflammation, hormonal changes, genetic predisposition, or exposure to certain chemicals
Eventually, they combined their studies of both hormones with another hormone, GLP-1, to create drugs that simultaneously target GLP-1, glucagon, and the GIP receptor
They resolve on their own
When working with your provider to optimize therapy, genetic and biomarker context may help guide formulation selection, dosing strategy, and adjunctive supportcreating a more informed, individualized approach
Acknowledgments This work was supported in part by Grants RO1 AI072648 (A.P.), R01AT004332 (A.P.), 5P30CA006516 (J.M.A.) and 5 P01CA120964 (J.M.A.) from the National Institutes of Health, and the Central New York Community Foundation (AP)